We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Unlocking Q2 Potential of MetLife (MET): Exploring Wall Street Estimates for Key Metrics
Read MoreHide Full Article
Analysts on Wall Street project that MetLife (MET - Free Report) will announce quarterly earnings of $2.30 per share in its forthcoming report, representing an increase of 13.9% year over year. Revenues are projected to reach $19.34 billion, increasing 7.9% from the same quarter last year.
Over the last 30 days, there has been a downward revision of 0.3% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
With that in mind, let's delve into the average projections of some MetLife metrics that are commonly tracked and projected by analysts on Wall Street.
Analysts forecast 'Revenue- Other Revenues' to reach $742.31 million. The estimate suggests a change of +9.3% year over year.
The combined assessment of analysts suggests that 'Revenue- Net investment income' will likely reach $5.50 billion. The estimate suggests a change of -2.8% year over year.
The consensus among analysts is that 'Revenue- Universal life and investment-type product policy fees' will reach $1.32 billion. The estimate points to a change of +4.7% from the year-ago quarter.
According to the collective judgment of analysts, 'Revenue- Premiums' should come in at $11.97 billion. The estimate suggests a change of +10.7% year over year.
Analysts predict that the 'Total Adjusted Revenue- Latin America' will reach $2.25 billion. The estimate suggests a change of +8.5% year over year.
Analysts' assessment points toward 'Adjusted Revenue- Corporate & other- Net investment income' reaching $974.37 million. The estimate indicates a year-over-year change of +1354.3%.
The consensus estimate for 'Total Adjusted Revenue- EMEA' stands at $846.38 million. The estimate indicates a year-over-year change of +8.5%.
The collective assessment of analysts points to an estimated 'Total Adjusted Revenue- Asia' of $3.11 billion. The estimate points to a change of +7% from the year-ago quarter.
It is projected by analysts that the 'Adjusted Revenue- Asia- Net investment income' will reach $1.39 billion. The estimate indicates a year-over-year change of +14.6%.
Based on the collective assessment of analysts, 'Adjusted Revenue- EMEA- Net investment income' should arrive at $67.41 million. The estimate suggests a change of +10.5% year over year.
Analysts expect 'Adjusted Revenue- Latin America- Net investment income' to come in at $440.74 million. The estimate indicates a change of -1% from the prior-year quarter.
The average prediction of analysts places 'Adjusted Revenue- Asia- Other Revenues' at $17.76 million. The estimate points to a change of -19.3% from the year-ago quarter.
Over the past month, shares of MetLife have returned +7.8% versus the Zacks S&P 500 composite's -0.5% change. Currently, MET carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
View the Zacks #1 Rank List
Image: Bigstock
Unlocking Q2 Potential of MetLife (MET): Exploring Wall Street Estimates for Key Metrics
Analysts on Wall Street project that MetLife (MET - Free Report) will announce quarterly earnings of $2.30 per share in its forthcoming report, representing an increase of 13.9% year over year. Revenues are projected to reach $19.34 billion, increasing 7.9% from the same quarter last year.
Over the last 30 days, there has been a downward revision of 0.3% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
With that in mind, let's delve into the average projections of some MetLife metrics that are commonly tracked and projected by analysts on Wall Street.
Analysts forecast 'Revenue- Other Revenues' to reach $742.31 million. The estimate suggests a change of +9.3% year over year.
The combined assessment of analysts suggests that 'Revenue- Net investment income' will likely reach $5.50 billion. The estimate suggests a change of -2.8% year over year.
The consensus among analysts is that 'Revenue- Universal life and investment-type product policy fees' will reach $1.32 billion. The estimate points to a change of +4.7% from the year-ago quarter.
According to the collective judgment of analysts, 'Revenue- Premiums' should come in at $11.97 billion. The estimate suggests a change of +10.7% year over year.
Analysts predict that the 'Total Adjusted Revenue- Latin America' will reach $2.25 billion. The estimate suggests a change of +8.5% year over year.
Analysts' assessment points toward 'Adjusted Revenue- Corporate & other- Net investment income' reaching $974.37 million. The estimate indicates a year-over-year change of +1354.3%.
The consensus estimate for 'Total Adjusted Revenue- EMEA' stands at $846.38 million. The estimate indicates a year-over-year change of +8.5%.
The collective assessment of analysts points to an estimated 'Total Adjusted Revenue- Asia' of $3.11 billion. The estimate points to a change of +7% from the year-ago quarter.
It is projected by analysts that the 'Adjusted Revenue- Asia- Net investment income' will reach $1.39 billion. The estimate indicates a year-over-year change of +14.6%.
Based on the collective assessment of analysts, 'Adjusted Revenue- EMEA- Net investment income' should arrive at $67.41 million. The estimate suggests a change of +10.5% year over year.
Analysts expect 'Adjusted Revenue- Latin America- Net investment income' to come in at $440.74 million. The estimate indicates a change of -1% from the prior-year quarter.
The average prediction of analysts places 'Adjusted Revenue- Asia- Other Revenues' at $17.76 million. The estimate points to a change of -19.3% from the year-ago quarter.
View all Key Company Metrics for MetLife here>>>Over the past month, shares of MetLife have returned +7.8% versus the Zacks S&P 500 composite's -0.5% change. Currently, MET carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .